A 6-month follow-up examination was recommended for women with mammographically detected breast lesions that are probably benign due to the small risk factor that the lesions are malignant, according to a study published in Radiology.
The Breast Imaging and Reporting System (BI-RADS) enabled researchers to closely examine the BI-RADS 3 category, who found that the malignancy rates in the BI-RADS 3 group significantly exceeded rates for women downgraded to the BI-RADS 1 and 2 groups.
“I thought that we should really look at this again now that we’ve got this large database we can work with and try to find out what happened with these patients,” study lead author Wendie A. Berg, MD, PhD, said in a press release.
Of the total population of women given BI-RADS 3 assessment after screening mammography recall, 810 (1.9%) were diagnosed with cancer. More, almost a third of women…
